Clinical Development Solutions
Taking a molecule from discovery to new treatment is a journey full of complexities and obstacles.Â
STRATEGIC PLANNING
To help optimise our engagement, we start by cycling our clients through a strategic validation process to establish optimal alignment with our capabilities. As an engagement formalises, we build a clear clinical development strategy with cross-interrogation of the trial protocol and clinical development roadmaps. This upfront planning ultimately minimises failure and reduces avoidable costs.
EVALUATE RISK
When preparing to initiate a clinical trial, we work to anticipate risks to critical data, processes and other significant study risks. We bring clinical expertise to portfolio- and study-level planning, harnessing the power of historical knowledge and thorough strategic planning.
A balanced study design
A well-designed protocol accounts for patient safety, data integrity and operational feasibility. Vx Pharma, together with its execution partners’ teams of medical, biostatistical and operational experts, will help you balance these sometimes-competing priorities, ensuring that your study design is optimally aligned for success.
We know that the success of your objectives depends on deep knowledge, planning and commitment
Taking a molecule from discovery to new treatment is a journey full of complexities and obstacles
Quantify patients, forecast enrolment and prepare for recruitment
The first step in recruiting and retaining patients is understanding target populations. Drawing on patient-group knowledge, we build a patient-focused foundation for participation, including targeted outreach and customised mid-trial support programs.
Fit-for-purpose monitoring protocols
Based on the risks to critical data and processes, we plan and implement the monitoring methods that best meet the needs of the clinical trial. We use monitoring approaches that include central, remote and onsite monitoring.
Phases
VX Pharma can assist with all trial phases but our strategy for success is to focus on our capabilities in which we have a proven legacy of successful delivery.
Our competitive advantage is in early phase research (safety to pivotal studies) where we can control the entire programme in a single global partner; as well as in large cohort outpatient studies in our core therapeutic areas. We can deliver a full pivotal study solution in these select therapeutic areas.
Discover our Therapeutic and Clinical Service Areas.
We know that the success of your objectives depends on deep knowledge, planning and commitment
Taking a molecule from discovery to new treatment is a journey full of complexities and obstacles
STRATEGIC PLANNING
To help optimise our engagement, we start by cycling our clients through a strategic validation process to establish optimal alignment with our capabilities. As an engagement formalises, we build a clear clinical development strategy with cross-interrogation of the trial protocol and clinical development roadmaps. This upfront planning ultimately minimises failure and reduces avoidable costs.
EVALUATE RISK
When preparing to initiate a clinical trial, we work to anticipate risks to critical data, processes and other significant study risks. We bring clinical expertise to portfolio- and study-level planning, harnessing the power of historical knowledge and thorough strategic planning.
A balanced study design
A well-designed protocol accounts for patient safety, data integrity and operational feasibility. Vx Pharma, together with its execution partners’ teams of medical, biostatistical and operational experts, will help you balance these sometimes-competing priorities, ensuring that your study design is optimally aligned for success.
Quantify patients, forecast enrolment and prepare for recruitment
The first step in recruiting and retaining patients is understanding target populations. Drawing on patient-group knowledge, we build a patient-focused foundation for participation, including targeted outreach and customised mid-trial support programs.
Fit-for-purpose monitoring protocols
Based on the risks to critical data and processes, we plan and implement the monitoring methods that best meet the needs of the clinical trial. We use monitoring approaches that include central, remote and onsite monitoring.
Phases
VX Pharma can assist with all trial phases but our strategy for success is to focus on our capabilities in which we have a proven legacy of successful delivery.
Our competitive advantage is in early phase research (safety to pivotal studies) where we can control the entire programme in a single global partner; as well as in large cohort outpatient studies in our core therapeutic areas. We can deliver a full pivotal study solution in these select therapeutic areas.
Discover our Therapeutic and Clinical Service Areas.
